Treatment of myelomatosis--M.R.C. trial.

نویسنده

  • D A Galton
چکیده

The zones can be measured by the fluorescence intensity emitted at an angle of 45'. The height and area of the peaks over the different zones corresponding to the fluorescence emission of that zone may be measured as relative percentages of the total fluorescence. The method uses unconcentrated early morning urine: 20 ILI are applied to paper and electrophoresed for four hours at 200 volts in Michaelis buffer (barbital/acetate), pH = 8.6, A = 0,075. Measurements were made on a Zeiss spectrophotometer PQ2 with the Sterzl additions of fluorescence equipment, scanner, and recorder. The irradiating light is passed through filter M 365, fluroescence being measured at 460 nm (maximum of fluorescence emission after excitation at 365 nm).

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The waning war on cancer.

In the Medical Research Council's lVth trial in Myelomatosis the possible benefit of adding vincristine to first line treatment with intermittent melphalan and prednisone has been assessed. This was analysed in 530 patients who were randomly allocated to receive vincristine or not. Survival was not improved by the addition of vincristine. A total of 268 patients reached plateau phase on first l...

متن کامل

Thromboembolic complications in myelomatosis.

Fourteen cases of myelomatosis associated with major thromboembolic complications are reported. Six patients died of pulmonary embolism, seven had deep-vein thrombosis as a presenting symptom, and three had evidence of amyloidosis. A preliminary estimate of the incidence of thromboembolism based on 376 patients admitted so far to the Medical Research Council's myelomatosis trial is about 3%, wh...

متن کامل

Total body irradiation for myelomatosis.

In the first myeloma trial of the M.R.C. working party on leukaemia in adults the deaths that have occurred can be attributed to unrelated diseases (5%h-for example, cosonary thrombosis, etc.); causes indirectly telated to the tumour (80,for example, pneumonia due to the immune paresis); no obvious response of the tumour to treatment (27/); and finally relapse of the tumour after an initial res...

متن کامل

Protein analyses in myelomatosis.

The criteria for the admission of patients to the Medical Research Council's (MRC) myeloma trials are the finding of abnormal plasma cells in bone marrow films or sections and in addition either of characteristic skeletal lesions demonstrated radiologically or of characteristic protein changes in the serum or urine. Ninety per cent of the patients in the first myeloma trial satisfied all three ...

متن کامل

Bulky extramedullary plasmacytomata: rare mode of relapse in myelomatosis.

In two cases of myelomatosis relapse was accompanied by the development of bulky extramedullary plasma cell tumours, which created serious management problems. In both cases the histology was of a poorly differentiated plasmacytoid tumour with frequent mitoses. In one case paraprotein had completely disappeared from the serum and urine after six months' treatment with melphalan alone but did no...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • British medical journal

دوره 2 5757  شماره 

صفحات  -

تاریخ انتشار 1971